Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ENDOMETRIOSIS study: dienogest versus Lunabell ULD after surgery for ovarian endometrioma
jRCT1051190028Completed
- Start
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial in endometriosis and endometrioma comparing Dienogest with Lunabell tablets ULD (2 arms). Primary endpoint: 2-year postoperative recurrence rate of ovarian endometrioma. Started Mar 2017; status: completed.
02
Drugs
dienogestnorethindrone + ethinyl estradiol
03
Conditions
endometriosisendometrioma
Beyond the preview
Go deeper on jRCT1051190028.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1051190028.